tumor suppressor gene

(Sbarro Health Research Organization) The tumor suppressor gene pRb2/p130 may provide the first independent prognostic biomarker in cases of soft tissue sarcoma, according to an international collaboration of researchers, including scientists at the Sbarro Institute for Cancer Research and Molecular Medicine at the College of Science and Technology at Temple University in Philadelphia, PA, the department of human pathology and oncology, University of Siena and the Center of Oncological Research of Mercogliano in Avellino, Italy.

(Journal of the National Cancer Institute) Also in the June 24 issue of JNCI are a study identifying a tumor suppressor gene associated with neuroblastoma outcomes, a novel strategy for developing tumor vaccines, an analysis of a region on chromosome 8 that is associated with several common cancers, a study that shows that using NSAIDs is not associated with melanoma risk, and a commentary that proposes a strategy for evaluating large epidemiologic studies such as the Nurses' Health Study.